Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000196

CHIEF BUSINESS OFFICER gave up 2,045 shares (to pay taxes)

  • CHIEF BUSINESS OFFICER acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Snow David P. CHIEF BUSINESS OFFICER 2020-01-30 Option exercise +6,250 6,250 D
Snow David P. CHIEF BUSINESS OFFICER 2020-01-30 Shares withheld for taxes −2,045 $3.91 $7,996 4,205 D
Derivatives
Snow David P. CHIEF BUSINESS OFFICER 2020-01-30 Option exercise · Restricted Stock Units +6,250 18,750 D
Loading xslF345X03/form4-01312020_050106.xml…